 NEW YORK, Aug. 05, 2021 GLOBE NEWSWIRE -- Checkpoint Therapeutics, Inc. Checkpoint NASDAQ: CKPT, a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the second quarter ended June 30, 2021. 